Document is current
Any future updates will be listed below
-
Authors
Kang, Dae-Wook http://orcid.org/0000-0002-2585-1974
Adams, James B.
Coleman, Devon M.
Pollard, Elena L.
Maldonado, Juan
McDonough-Means, Sharon
Caporaso, J. Gregory http://orcid.org/0000-0002-8865-1670
Krajmalnik-Brown, Rosa http://orcid.org/0000-0001-6064-3524
-
Funding
Funding for this research was provided by:
This work was supported by Finch Therapeutics and the Arizona Board of Regents.
- License Information
-
More Information
Article History
Received: 3 December 2018
Accepted: 5 March 2019
First Online: 9 April 2019
Competing Interests
: J.B.A., D.-W.K. and R.K.B. have pending/approved patents related to the use of FMT and/or probiotics for various conditions including autism (Application number: 14/403,425 (approved and active); 15/290,798 (pending)). J.B.A., R.K.B. and D.-W.K. have received research funding from Crestovo/Finch Therapeutics for FMT research. J.B.A., R.K.B. and J.G.C. have received consulting fees from Crestovo. The other authors declare no competing interests.
